Interventional oncology procedures comprise diagnosis and treatment of cancer with the help of minimally invasive procedures that are conducted under image guidance.
The total market value of Global Interventional Oncology Market is $1,984.00 million in 2021.
The forecast period for Global Interventional Oncology Market is 2022 to 2031.
The market value of Global Interventional Oncology Market in 2031 is $4,127.21 million.
Boston Scientific Corporation, Medtronic Inc., Merit Medical Systems, Inc., Terumo Corporation, and Siemens Healthineers AG held a high market position owing to the strong geographical foothold in different regions.
Particle Embolization segment dominates the global market, owing to growing demand of embolization particles for interventional oncology and interventional cardiovascular procedure, and favorable reimbursement scenario.
The major factor for the growth of global Interventional Oncology market are high prevalence and growing incidences of cancer. There has also been recent technological advancements, increasing funding from private and government organizations, and growing adaptions of interventional oncology methods for the diagnosis and the treatment of cancer with superior imaging technologies and minimally invasive procedures.
Owing to constantly improving economic conditions and rising healthcare expenditure in several emerging economies.
The base year is 2021 in Global Interventional Oncology Market.
Interventional oncology focuses on the diagnosis, treatment and the relief of cancer and other cancer-related issues using minimally invasive procedures performed under image guidance.
Loading Table Of Content...
Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?